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The aim of this study was to document some epidemiological features of termination of pregnancy for birth defects in Iran. We
studied 603 pregnant women who were diagnosed/recommended for the termination of pregnancy as having a fetus with some
types of birth defect(s). Most women (87.2 percent) had at least one ultrasound examination. The proportion of other screening
testsincludingamniocentesisandgenetictestswere2.8and4.6percent,respectively.Of603women,201terminatedthepregnancy
giving a prevalence rate of 33.3 percent (CI 95%: 29.6–37.6). The remaining 402 subjects were unable to get the permission for
abortion because of untimely diagnosis/application for termination (20th week of pregnancy and/or later). Forty-eight percent
of termination of pregnancies was performed before the 18th week of pregnancy. Neural tube defects, limb deformation, hydrops
fetalis, hydrocephaly, and chromosomal anomalies including Down syndrome accounted proportionally for about 65 percent of
defects eligible for abortion in the region. Although the rate of termination of pregnancy for birth defects is acceptable at the
current situation in the country, more eﬀorts should still be made to convince the community authorities to give more possibility
and ease for the termination of pregnancy for congenital anomalies.
1.Introduction
Therapeutic abortion is deﬁned as intentional termination
of pregnancy performed or authorized by a physician in
order to save the mother’s life and health. Termination of
pregnancy is legally allowed in Iran if three specialist phy-
siciansconﬁrmthattheoutcomeofpregnancymaybeharm-
ful, for any reason, for mother/family during pregnancy or
after birth. The reasons for this termination include the fol-
lowing circumstances: (a) complications during the preg-
nancy endangering mother’s health and (b) termination of
pregnancy due to major malformation of fetus [1, 2].
According to the current laws in Iran, the permission
for termination is only issued before the 20th week of pre-
gnancy. According to the country’s current religious rules
and traditions, it is believed that fetal viability occurrs after
the 20th week, and it would not then be allowed to abort the
fetus after this time [3, 4].
Currently, in Iran, one of the main reasons for termi-
nation of pregnancy is congenital anomalies. Many of the
serious maternal and fetal conditions are now easily per-
mitted for abortion in the country (Tables 3 and 4)[ 2, 4].
In addition to those conditions, if three specialist physicians
conﬁrm that the outcome of pregnancy may be harmful for
any other reason to mother/family during pregnancy or after
birth, the abortion will also be permitted even if it is not in-
cluded in the list.
The aim of this study was to describe the epidemiological
proﬁle of induced abortions in women with birth defects in
the northwest of Iran during 2010.
2. Methods
Tabriz Registry of Congenital Anomalies (TRoCA) covers
an annual average of 20000 births in the northwest of
Iran, including live births and stillbirths [5]. As for current
screening programme and pregnancy checkups in Iran,
all pregnant women are routinely examined in public or
private clinics by a gynecologist, obstetrician, or midwife.
Ultrasoundexaminationisoneoftheroutinediagnostictests2 Journal of Pregnancy
Table 1: Basic characteristics of study subjects.
Group I n = 201 95% CI Group II n = 402 95% CI
Number Percent Lower Upper Number Percent Lower Upper
Mother literacy
Primary/secondary 120 59.7 52.7 66.7 275 68.4 63.7 72.9
High school 60 29.9 23.9 36.3 98 24.4 20.4 28.6
University 21 10.4 6.5 14.9 29 7.2 4.7 9.7
Father literacy
Primary/secondary 134 66.7 60.7 73.6 253 62.9 58.0 67.9
High school 42 20.9 14.9 26.9 89 22.1 17.9 26.1
University 25 12.4 8.0 17.4 60 14.9 11.7 18.4
Mother job Housewife 181 90.0 86.1 94.0 370 92.0 89.3 94.5
Employed 20 10.0 6.0 13.9 32 8.0 5.2 10.7
Family income (per month, US $)
Less than 400 129 64.2 57.7 70.1 245 60.9 56.2 65.7
400–800 56 27.9 21.4 34.3 139 34.6 29.6 39.3
More than 800 16 7.9 4.5 11.9 18 4.5 2.7 6.5
Type of marriage Familial 56 27.9 21.9 33.8 154 38.3 33.6 43.5
Nonfamilial 145 72.1 66.2 78.1 248 61.7 56.5 66.4
Mean (95% CI) Mean (95% CI)
Mother age 29.14 (28.24–29.97) 27.87 (27.34–28.41)
Father age 33.47 (32.51–34.42) 33.61 (33.04–34.17)
for maternal care in the country. It is usually performed 3-4
times during pregnancy period beginning from early weeks
and then in the 12th, 22nd, and 32nd weeks of pregnancy. It
is recommended to do one of the ultrasound examinations
between 14th and 16th weeks for birth defect(s) diagnosis.
The same routine care are given after birth for infants by
neonatologist or pediatrician—both at birth and at hospital
discharge—for possible intervention and treatment. The
examinations include assessment of maternal health status,
maturity, and congenital anomalies of fetus/infant during
pregnancy and after birth. We studied 603 women with a
pregnancy complicated by a birth defect in the population
under the TRoCA programme. They were identiﬁed by med-
ical diagnostic tests during the antenatal period as having
a fetus with birth defect(s). Pregnant mothers were then
referred to three specialist physicians for ﬁnal conﬁrmation
of congenital anomalies. Of them, 201 mothers were legally
allowed to proceed to abortion (Group I), and the remaining
402 subjects were unable to obtain permission for abortion
(Group II). The deﬁnition of the congenital anomalies
for the purposes of this study is based on the standard
coding system of the International Classiﬁcation of Diseases
(ICD) and British Paediatric Association (BPA). Thus, the
study subjects comprised all pregnant women who were
diagnosed/recommended for the termination of pregnancy
as having a fetus with some types of birth defect(s) with a
primary diagnosis under one of the anomalies headings.
After obtaining an informed consent from the partic-
ipants, an expert physician performed the clinical exami-
nations and took the medical history of the subjects. All
mothers were also asked to complete a brief questionnaire
for demographic characteristics and socioeconomic status.
Approval for this study was obtained from Regional
Committee of Medical Ethics of Tabriz University of Medical
Sciences.
Descriptive statistics (including proportions, means, and
standarddeviations)and95%conﬁdenceintervalswereused
for statistical analysis of data.
3. Results
There were a total of 22524 births (22320 live and 204
stillbirths) in the area in 2010. Of those, 639 pregnancies
(2.8 percent, CI95%: 2.6–3.0) were identiﬁed as having a
fetus with birth defect(s).Demographic characteristics of the
studysubjectsareshowninTable 1.Themeanageofmothers
was 28.3 years (range: 14–44 years). Thirty-ﬁve percent of
subjects had consanguineous marriage. Eighty cases had a
history of anomaly in previous pregnancies, 65 had the
same anomaly in father’s family compared to the 42 cases
with the similar anomaly in mother’s family. Most women
(87.2 percent) had at least one ultrasound examination. The
proportions of other screening tests including amniocentesis
and genetic tests were 2.8 and 4.6 percent, respectively. Of
603 women diagnosed as having a baby with birth defect,
201 terminated the pregnancy giving a prevalence rate of
33.3 percent (CI95%: 29.6–37.6). Forty-eight percent of
termination of pregnancies was performed before the 18th
week of pregnancy. Neural tube defects, limb deformation,
hydrops fetalis, hydrocephaly, and chromosomal anomalies
including Down syndrome accounted proportionally for
about 65 percent of defects eligible for abortion in the region
(Table 2).
4. Discussion
This study was carried out to produce the epidemiological
proﬁle of induced abortions for birth defects in Iran. The
prevalenceofpregnancies complicatedbycongenitalanoma-
lies was estimated 2.8 percent of total births in the region.Journal of Pregnancy 3
Table 2: Termination of pregnancy by the type of birth defects.
Type of anomaly Group I Group II Total
Number Percent Number Percent Number Percent
Down syndrome 14 7.0 37 9.2 51 8.5
Hydrocephaly 19 9.5 50 12.4 69 11.4
Chromosomal anomaly 3 1.5 9 2.2 12 2.0
Limb deformation 14 7.0 48 11.9 62 10.3
H e a r t a n o m a l y 73 . 551 . 2 1 2 2 . 0
Hydrops fetalis 26 12.9 35 8.7 61 10.1
Spinal muscular atrophy 8 4.0 7 1.7 15 2.5
Oligohydramnios 21 10.4 28 7.0 49 8.1
Microcephaly 7 3.5 25 6.2 32 5.3
Polyhydramnios 8 4.0 19 4.7 27 4.5
Major thalassemia 6 3.0 0 0.0 6 1.0
Neural tube defects 44 21.9 92 22.9 136 22.6
Others 24 11.9 47 11.7 71 11.8
Table 3: List of maternal indications of therapeutic abortion in Iran.
(1) Any of the cardiac valve diseases with functional class 3-4 heart failure that is not reversible to class 2
(2) Any kind of acute heart disease except coronary heart disease that has reached functional class 3-4 (e.g., myocarditis and pericarditis)
(3) History of dilated cardiomyopathy in previous pregnancies
(4) Marfan syndrome, when ascending aorta is wider than 5 cm
(5) Eisenmenger’s syndrome
(6) Pregnancy-induced fatty liver
(7) Grade 3 esophageal varicosities
(8) History of esophageal varicosities hemorrhage followed by portal hypertension
(9) Uncontrollable autoimmune hepatitis
(10) Renal failure
(11) Hypertension which is not controllable with permitted drugs during pregnancy
(12) Any of the pulmonary diseases that lead to pulmonary hypertension even to a mild degree (emphysema, ﬁbrosis, diﬀuse
bronchiectasis)
(13) Any infection with HIV virus which has entered into the phase of AIDS disease
(14) Hypercoagulability when using heparin leads to progression of other diseases that can threat’s motheren life
(15) Active uncontrollable SLE which has involved a major organ
(16) Vasculitis (when major organs are involved)
(17) All CNS masses with considering their type and location, when beginning the treatment is dangerous to fetus and without treatment
mother-life may be threatened
(18) Pemphigus vulgaris and severe generalized psoriasis and advanced melanoma
(19) Multidrug-resistant epilepsies
(20) MS cases in which the patient is disabled
(21) Myasthenia gravis
(22) Some type of motor neuron diseases like ALS which is intensiﬁed following pregnancy and will seriously endanger mother’s life
One-third of women with a fetus with birth defect(s) had
consanguineous marriage. Most of them reported to have
at least one ultrasound examination during the pregnancy.
Major anomalies for abortion included neural tube defects,
limb deformation hydrops fetalis, hydrocephaly, and chro-
mosomalanomalies.Ourﬁndingswereconsistentwithother
studies previously reported in terms of demographic and
socioeconomic indicators [6–9]. However, one of the main
reasonsfortheterminationofpregnancieswasthalassemiain
previous studies where it was rare in our investigation. This4 Journal of Pregnancy
Table 4: List of fetal indications of therapeutic abortion in Iran.
(1) Osteogenesis imperfecta
(2) Osteochondrodysplasia
(3) Osteopetrosis and infantile neuroaxonal dystrophy
(4) Bilateral renal agenesis
(5) Polycystic kidney
(6) Multicystic dysplastic kidney
( 7 )P o t t e rs y n d r o m e
(8) Congenital nephrotic syndrome and hydrops
(9) Severe bilateral hydronephrosis
(10) Alpha thalassemia and hydrops fetalis
(11) Thrombotic disorders
(12) Trisomy 13, 18, 3, 16, and 8
(13) Anencephaly
(14) Cat cry syndrome
(15) Holoprosencephaly
(16) Syringomyelia
(17) Cranioschisis
(18) Meningoencephalocele
(19) Meningohydroencephalocele
(20) Thanatophoric dysplasia
(21) Cyclopia with holoprosencephaly
(22) Ichthyosis congenita
(23) Schizencephaly
shows that thalassemia is now under the control of health
care system in the country as reported before [10].
In three out of every ﬁve pregnancies with congenital
abnormalities, consent for terminating the pregnancy could
not be obtained as the diagnosis/application only occurred
after 20 weeks indicating that early diagnosis and timely
request would be essential to get the abortion permit.
It is concluded that one in almost three pregnancies
prenatally diagnosed with birth defect(s) is now legally
terminated in Iran. Although this ﬁgure is acceptable at the
current situation in the country, more eﬀorts should still be
madeto(a)convincethecommunityauthoritiestogivemore
possibility and ease for the termination of pregnancy for
congenitalanomalies,(b)improvethediagnosticfacilitiesfor
early and timely diagnosis of fetal anomalies, (c) train med-
ical staﬀ in the clinical indications of therapeutic abortion of
birth defects, and (d) provide the necessary information to
young couples about the suitable age of pregnancy and about
folic acid consumption before and during pregnancy.
Appendix
See Tables 3 and 4.
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